Access Bio Overview

  • Status
  • Public
  • Employees
  • 65
Employees
  • Stock Symbol
  • 950130
Stock Symbol
  • Share Price
  • $18.32
  • (As of Monday Closing)

Access Bio General Information

Description

Access Bio Inc is a United States based bio company engaged in the research, development, and manufacturing of in vitro rapid diagnostic tests, biosensor, and molecular diagnostic products. The products are for the prevention and early diagnosis of infectious diseases. The company's core in vitro-diagnostic technology includes immunochemical, biochemical and molecular products. The company offers products for Rapid Diagnostic Tests including CareStart G6PD RDT, CareStart Malaria, CareStart Dengue Combo, and CareStart Scrub Typhus IgM; Biosensors product includes CareStart G6PD Biosensor, and Molecular Diagnostics products include CareStart HPV and CareStart CAH.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Clinics/Outpatient Services
Other Industries
Other Healthcare Services
Drug Discovery
Stock Exchange
KRX
Primary Office
  • 65 Clyde Road
  • Suite a
  • Franklin Township, NJ 08873
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Access Bio Stock Performance

(As of Monday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$18.32 $18.59 $2.56 - $53.02 $662M 35.6M 1.92M $4.20

Access Bio Financials Summary

In Thousands,
USD
TTM 31-Mar-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018
EV 388,626 662,708 87,057 135,747
Revenue 290,622 103,157 36,926 36,611
EBITDA 215,714 57,282 (13,883) (1,330)
Net Income 147,389 40,885 (15,083) (3,858)
Total Assets 294,002 156,001 60,198 84,807
Total Debt 34,800 43,329 32,915 38,793
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Access Bio Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Access Bio‘s full profile, request access.

Request a free trial

Access Bio Executive Team (2)

Name Title Board Seat Contact Info
Young Ho Choi Founder, Chairman, Chief Executive Officer & President
You’re viewing 1 of 2 executive team members. Get the full list »

Access Bio Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial